Loading
institutionsInstitution
The Christie NHS Foundation Trust
The Christie is Europe's largest single-site cancer centre and the UK's first NHS proton therapy centre.
Overview
The Christie NHS Foundation Trust in Manchester is Europe's largest single-site cancer centre and the first NHS proton beam therapy centre, opened in 2018; it ranks twenty-third in the Newsweek/Statista oncology list and is tied to the University of Manchester. It runs one of the largest early-phase trial units in Europe and, with Cancer Research UK, the Manchester Cancer Research Centre, with Corinne Faivre-Finn, Caroline Dive, Ananya Choudhury, Andrew Wardley and Juan W. Valle among its people. OnCo links it to bladder cancer, lymphoma and mesothelioma, and to ideas on core-funded radiotherapy trials, evening trial clinics for working-age patients and lung screening in supermarket car parks. Fragmented care and guideline gaps are the bottleneck it most often meets. Its proton and early-phase programmes are the place to start.
Location
Manchester, GB
Type
cancer center · University of Manchester
Website
Newsweek 2026 oncology rank
#23
OnCo score
#19 · 97 points (37 Newsweek + 0 NCI + 60 from 30 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-24.
Matched to The Christie Hospital, including child institutions. 105 works · 2,179 citations · 71% open access · 20% clinical trials · 1% reviews.
Oncology works per year
282022
272023
202024
142025
162026
Most works
- Maeve O’Reilly18 works
- Caroline Besley17 works
- Claire Roddie17 works
- Andrea Kühnl16 works
- Robin Sanderson14 works
- Sridhar Chaganti14 works
- Tobias Menne13 works
- Amy A. Kirkwood12 works
- Adrian John Clifton Bloor12 works
- Wendy Osborne12 works
Most cited
- Proton therapy
- Early-phase trials
- Radiotherapy research
Ananya Choudhury
Professor of Clinical Oncology, University of Manchester; Consultant, The Christie
Bladder cancer radiotherapyHypoxia biomarkersRadiobiology
Ananya Choudhury is a clinical oncologist developing biomarker-guided radiotherapy for bladder cancer.
Andrew Wardley
Consultant Medical Oncologist, The Christie; Honorary Professor, University of Manchester
Breast cancerHER2-positive diseaseAdjuvant trials
Andrew Wardley is a breast oncologist involved in the PERSEPHONE trial of shorter trastuzumab.
Anne Armstrong
Consultant in Medical Oncology and Honorary Senior Lecturer, The Christie; Co-Chair of the Breast Disease Group
Breast cancerTriple-negative breast cancerImmunotherapy window trials
Medical oncologist who co-chairs the breast disease group at The Christie, the Manchester cancer centre that is a site of the PHOENIX, PARTNER and ASCENT-05 trials for triple-negative disease.
Ashya King
Child whose family's fight for proton therapy changed access in Britain
MedulloblastomaProton therapyPatient and family choice
In 2014 his parents took him from a British hospital to seek proton beam therapy for a brain tumour abroad, were arrested, then vindicated. The case sped the building of NHS proton centres.
Caroline Dive
Director, Cancer Research UK Manchester Institute; Professor of Cancer Pharmacology
Liquid biopsyCirculating tumour cellsSmall-cell lung cancer models
Built small-cell lung cancer models from circulating tumour cells and leads the Manchester institute.
Corinne Faivre-Finn
Professor of Thoracic Radiation Oncology, University of Manchester and The Christie
Small-cell lung cancer radiotherapyThoracic radiotherapyRadiotherapy-immunotherapy combinations
Led CONVERT, which set the radiotherapy schedule for limited-stage small-cell lung cancer.
Fiona Blackhall
Professor of Thoracic Oncology, University of Manchester; Consultant, The Christie
Lung cancerSmall-cell lung cancerBiomarker-driven trials
Fiona Blackhall is a thoracic oncologist leading small-cell lung cancer trials and biomarker research at The Christie.
Juan W. Valle
Chief Medical Officer, Cholangiocarcinoma Foundation; Honorary Professor of Medical Oncology, University of Manchester and The Christie
Biliary tract cancerCholangiocarcinomaChemotherapy and immunotherapy
Led ABC-02, which made gemcitabine plus cisplatin the global standard for biliary cancer, and co-led TOPAZ-1.
Mairéad McNamara
Senior Lecturer in Medical Oncology, University of Manchester; Honorary Consultant, The Christie
Biliary tract cancerHepato-pancreato-biliary cancersNeuroendocrine neoplasms
Leads biliary tract cancer trials at The Christie, the Manchester centre behind the ABC trial series, and is a member of the international biliary trial collaborations.
Philip Crosbie
Professor of Respiratory Medicine, University of Manchester; Honorary Consultant, Wythenshawe Hospital, Manchester University NHS Foundation Trust
Early detection of lung cancerCommunity low-dose CT screeningLung health checks
The Manchester respiratory physician who showed that if you park a CT scanner in a supermarket car park in a poor part of the city, people come, and the cancers you find are early ones.
Rob Bristow
Representative of The Christie NHS Foundation Trust to the Organisation of European Cancer Institutes
Cancer centre representation (OECI)
Rob Bristow represents The Christie NHS Foundation Trust in the Organisation of European Cancer Institutes, which lists the centre among its members in United Kingdom.
Similar pages
- TrialABC-06
Shares Mairéad McNamara, Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial, Juan W. Valle, Gallbladder cancer roadmap: from a chance finding at gallstone surgery to a disease with its own trials.
- IdeaGrow blood-borne tumour cells to test drugs on the cells that actually spread
Shares Fiona Blackhall, Caroline Dive, Small-cell lung cancer, Prostate cancer.
- InstitutionThe Royal Marsden
Shares Evening and weekend trial clinics for working-age patients, A statutory minimum share of public trial money for surgery and radiotherapy, Precision-Panc, MR-guided adaptive radiotherapy.
- InstitutionUniversity Hospitals Birmingham / University of Birmingham Cancer Research Centre
Shares VIOLET, AMMF, the Cholangiocarcinoma Charity, Precision-Panc, Bladder & urothelial cancer.
- InstitutionUniversity College London Hospitals / UCL Cancer Institute
Shares ABC-12, AMMF, the Cholangiocarcinoma Charity, Precision-Panc, Proton therapy machines: cyclotrons, synchrotrons and single-room systems.
- IdeaTreat the deprivation gradient in lung cancer as a defect in delivery that can be fixed and measured
Shares Take lung screening scanners to supermarket car parks in the poorest areas, Fragmented care and guideline gaps, Small-cell lung cancer, Lung cancer (all types).
- Key paperSocioeconomic inequalities in lung cancer treatment: systematic review and meta-analysis
Shares Take lung screening scanners to supermarket car parks in the poorest areas, Fragmented care and guideline gaps, Small-cell lung cancer, Lung cancer (all types).
- IdeaPublish the four numbers the NHS lung cancer pathway does not currently measure: reflex testing rate, genomic turnaround, surgical access and a lung-specific waiting time in every nation
Shares Take lung screening scanners to supermarket car parks in the poorest areas, Fragmented care and guideline gaps, Small-cell lung cancer, Lung cancer (all types).